The IPO Buzz: Genes, Drugs and Clarity
It looks as if the only IPOs to get out the door so far this year are from the health-care sector plus a “blank check” offering. This week has two health-care deals and one “blank check.” Nevertheless, the mislabeling of certain health-care IPOs creates a case of mistaken identity. The financial press insists on labeling […]
February 28, 2016 Read More